MedPath

VertiGreens Investigating the Effects of Iron Biofortification of Microgreens on Iron Status in Women

Not Applicable
Not yet recruiting
Conditions
Iron Biomarkers/Status
Registration Number
NCT06972927
Lead Sponsor
University of Aberdeen
Brief Summary

The investigators present a diet intervention study, to be conducted as a within-subject design, to assess the effect of the provision of iron biofortified microgreens on iron intake and status in women of reproductive age and postmenopausal women. This will be investigated by providing smoothie kits for 28 days containing these microgreens and determining the impact on iron biomarkers. The investigators will also assess habitual diet, BMI, physical activity and gastrointestinal symptoms. This study will be a proof-of-concept exploratory study to explore diet based biofortification through vertical farming systems.

Detailed Description

In this study microgreens that were grown using agronomic iron biofortification will be supplied to women to add to their diet to establish the potential nutritional impact of iron biofortified microgreens on overall iron intake and iron status. Furthermore, it will assess the adherence to the provided consumption recommendations of the biofortified crops.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Healthy females
  • 15 of reproductive age (18-49)
  • 15 postmenopausal (not had their period for an entire year)
Exclusion Criteria

Medication exclusion criteria:

  • Supplementing iron or vitamin B12
  • Smoking or vaping
  • Taking anticoagulant medication (blood thinners) except for Aspirin 75mg

Medical exclusion criteria:

  • Anyone who is planning to be pregnant, is pregnant or breastfeeding
  • Anyone with iron or vitamin B12 deficiency anaemia
  • Anyone with history of anaemia in the past 3 months that required treatment
  • Anyone who has Hb <120 g/L (12 g/dL) at screening
  • Anyone with food allergies, self-reported food sensitivity or intolerance
  • Anyone with coeliac disease or gluten intolerance
  • Anyone suffering from a psychiatric disorder or any type of substance abuse
  • Anyone with Type 1 diabetes and Type 2 diabetes
  • Anyone suffering from unregulated thyroid disease
  • Anyone with gastrointestinal conditions or bariatric surgery
  • Anyone with haematological conditions including Thrombocytopaenia and Sickle cell anaemia

Other exclusion criteria:

  • Anyone with unsuitable veins for blood sampling
  • Anyone who donated blood in the last 16 weeks
  • Anyone who is unable to fluently speak, read and understand English

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Haemoglobin status change from baselineMeasured at study day 1 and on study day 28

Iron status changes in haemoglobin

Serum iron status change from baselineMeasured at study day 1 and on study day 28

Iron status changes in serum iron

Ferritin status change from baselineMeasured at study day 1 and on study day 28

Iron status changes in ferritin

CRP change from baselineMeasured at study day 1 and on study day 28

Changes in CRP

Dietary iron intake changes compared to habitual dietevery study day (28 days)

Dietary iron intake changes in iron intake compared to habitual diet measured though food diaries

Secondary Outcome Measures
NameTimeMethod
Serum Vitamin B12 status change from baselineMeasured on study day 1 and on study day 28

Vitamin B12 status changes

Adherence to consumption of microgreens/smoothieevery study day (28 days)

intake measured through food diaries

Trial Locations

Locations (1)

Rowett Institute, University of Aberdeen

🇬🇧

Aberdeen, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath